- Primary research
- Open Access
Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample
Annals of General Psychiatry volume 7, Article number: 4 (2008)
The Hospital Anxiety and Depression Scale (HADS) has been used in several languages to assess anxiety and depression in general hospital patients with good results.
The HADS was administered to 521 participants (275 controls and 246 inpatients and outpatients of the Internal Medicine and Surgical Departments in 'Attikon' General Hospital in Athens). The Beck Depression Inventory (BDI) and the State-Trait Anxiety Inventory (STAI) were used as 'gold standards' for depression and anxiety respectively.
The HADS presented high internal consistency; Cronbach's α cofficient was 0.884 (0.829 for anxiety and 0.840 for depression) and stability (test-retest intraclass correlation coefficient 0.944). Factor analysis showed a two-factor structure. The HADS showed high concurrent validity; the correlations of the scale and its subscales with the BDI and the STAI were high (0.722 – 0.749).
The Greek version of HADS showed good psychometric properties and could serve as a useful tool for clinicians to assess anxiety and depression in general hospital patients.
The Hospital Anxiety and Depression Scale (HADS) was developed by Zigmond and Snaith  in 1983. Its purpose is to provide clinicians with an acceptable, reliable, valid and easy to use practical tool for identifying and quantifying depression and anxiety. The role of the scale is dimensional rather than categorical; it is best used not to make diagnoses of psychiatric disorders, but for identifying general hospital patients who need further psychiatric evaluation and assistance .
Depression and anxiety among general hospital patients could be much higher than is generally assumed, compounding the basic medical condition prognosis. The prevalence of depression in medical and surgical inpatients in Greece, using the Beck Depression Inventory (BDI) , was found to be 29% . Proportional findings also include cancer patients (20–25%) . Not only general hospital patients, but also cancer patients have reported that they might benefit from specific interventions aimed at psychological symptoms .
The HADS has been translated and widely used in more than 25 countries since its original development . Herrmann, in an extended review, reported that the HADS has demonstrated reliability and validity when used to assess medical patients . Bjelland reached similar conclusions in his review 5 years later . The HADS has been used in the general population [8–10], on general hospital patients [11–14], in cancer care settings [15–17], and even in HIV patients . The HADS has been translated into Greek and validated in a palliative care unit for cancer patients with good results .
The aim of this study was to validate the Greek translation of the HADS, and assess its psychometric properties in general hospital patients.
The study was performed by the Second Department of Psychiatry at the 'Attikon' General Hospital in Athens. Three groups participated; one group of elderly inpatients in the Internal Medicine and Surgical Departments, one group of outpatients waiting to be examined in the Internal Medicine Outpatients Department and one general population group which was assessed by mail (this group is referred to as 'controls'). A total of 521 participants completed the study; 246 patients and 275 controls.
The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0–3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0–21). It is worth noting that items referring to depression symptoms that describe somatic aspects of depression (e.g. insomnia and weight loss) are not included in the scale. The Greek translation by 'nFer Nelson Publishing' (The Chiswick Centre, 414 Chiswick High Road, London, UK) was used with permission.
The Beck Depression Inventory (BDI) was used to measure depression. It is designed to examine both somatic and cognitive aspects of depression. The BDI is a 21-item self-reporting scale that has been used, apart from its original purpose (assessment of the severity of known depression), for screening purposes. The Greek version has been translated and validated previously  and has been widely used to date.
The State-Trait Anxiety Inventory (STAI) developed by Spielberger is used to measure anxiety. It is a 40-item scale made up of two 20-item subscales (one state and one trait), and has been widely used to asses anxiety not only in clinical but in non-clinical samples. The STAI (Form X) has been translated and validated in Greek . The BDI and STAI were administered to patients only.
All of the scales used are self-rated and were administered by five of the researchers. The aim was that the examiners would interfere as little as possible in the patient's completion of the scales. For homogeneity of the results, the scoring of the scales was performed by only one of the researchers.
The following tests were used for the statistical analysis of the data: the Pearson Chi-square test was used for comparison of percentages, and thee Student t test and one-way analysis of variance (ANOVA, with Bonferroni correction) for comparison of means of variables. Correlations were tested by the Pearson r or the Spearman rs coefficients, depending on whether the variables were normally distributed or not. The psychometric properties of the HADS were evaluated by the following: construct validity was assessed by inter-item and inter-scale correlations and exploratory factor analysis (principal components with varimax rotation). The intraclass correlation coefficient was used to explore the test-retest reliability. The internal consistency of the scale was calculated with Cronbach's alpha coefficient (minimum acceptable value for alpha was 0.7). Concurrent validity was assessed by calculating correlations between the HADS and the BDI (the gold standard for depression) and the STAI (the gold standard for anxiety). Statistical analysis was carried out using SPSS (Version 11.0) for Windows (SPSS Inc., Chicago, IL, USA).
The demographic data for the participants are listed in Table 1. The patients group consisted of two subgroups: 150 inpatients (elderly inpatients of age > 65 years attending the Internal Medicine and Surgical Departments) and 96 outpatients of all ages waiting to be examined in the Internal Medicine Outpatients Department. The differences in age and sex among the three groups were of statistical significance.
The mean scores for HADS, BDI and STAI are listed in Table 2. Comparing patients as a whole to the controls (t test) showed that patients had greater values as assessed by HADS, HADS-D (depression) and HADS-A (anxiety) with a level of statistical significance p < 0.001. The same finding was generally observed when inpatients and outpatients were compared to controls separately and to each other (using ANOVA after Bonferroni correction); inpatients and outpatients showed higher scores than controls. It is worth noting that although inpatients and outpatients had similar scores on the HADS-D, outpatients showed higher scores on the HADS-A.
Zigmond and Snaith  have suggested two cut-off scores for detecting depression and anxiety that have generally been used in most studies; scores of 8 to 10 = doubtful cases, and scores of 11 and higher = valid cases. Bjelland et al., in their review, report that most studies conclude the cut-off score of 8 in general population and in somatic patients samples is correct . The same score has been recently proposed by Olsson et al. for outpatients . In our patient sample (inpatients and outpatients), the prevalence of doubtful cases was 14.2% for depression and 16.3% for anxiety. The prevalence of valid cases was 13.4% for depression and 15.1% for anxiety. These percentages for patients only were 22.3% for doubtful cases for depression and 17.4% for anxiety and 22.7% for valid cases for depression and 21.9% for anxiety.
Psychometric properties of HADS
The HADS Cronbach's α value for the total HADS was 0.884, for anxiety 0.829 and for depression 0.840. Construct validity measured by item-scale correlations ranged from 0.540 to 0.804 and were always higher for each item with its factor (anxiety or depression). For details see Table 3.
Fifty of the controls, randomly selected, completed the HADS on two occasions with a 20-day interval. Both the total scale and the two subscales showed high retest stability. The intraclass correlation coefficient for the total HADS was 0.944, for the HADS/anxiety 0.899 and for the HADS/depression 0.837. None of the scales showed statistically significant differences between test and retest.
The HADS has a two-factor structure; factor I for depression and factor II for anxiety. All items, with the exception of item 14 (detecting depression), showed higher scores for the factor they were expected to. The factor loadings are shown in Table 4.
The correlation between the anxiety factor II of the HADS and the STAI (state) was 0.628 (p < 0.001) and the correlation between depression factor I of the HADS and the BDI was 0.661 (p < 0.001). Correlations between the subscales: HADS/anxiety with HADS/depression: 0.559.
The BDI and STAI were used as gold standards to assess depression and anxiety correspondingly. The correlations between the BDI and STAI and the total HADS were high; BDI: 0.749, STAI (state): 0.758. The correlation between the HADS/anxiety and STAI (state) was 0.774, and between the HADS/depression and BDI: 0.722 (p < 0.001).
In the present study, the HADS was tested on a sample of Greek general hospital patients (inpatients and outpatients), and controls from the community. The HADS appears to have high internal consistency; Cronbach's α value for the total HADS was 0.884.
The Greek version of the HADS seems to be bidimensional; thus, it could be considered that the two subscales of the HADS measure anxiety and depression independently. The HADS and its two subscales showed high correlations with the gold standards that were used to measure depression (BDI) and anxiety (STAI).
As expected, patients in general appeared to be more depressed and anxious than the subjects from the general population (controls). Outpatients seemed to be more affected than inpatients in presenting anxiety. This could be attributed to the outpatients' concern about hearing bad news as a result of their consultation. By contrast, inpatients are in a way settled in the 'safety' of the ward.
The psychometric properties of the G reek version of the HADS are similar with those of other languages [8, 9, 12–14]. The HADS generally appears to have a high internal consistency; Cronbach's α values ranged from 0.870 to 0.885 for all the items of the scale. The item-subscale correlations were moderate to high; from 0.608 to 0.762 for the anxiety items, and from 0.540 to 0.804 for the depression items. The HADS appears to be bidimensional as in the original study by Zigmond and Snaith . All items but one (item 14) loaded in the appropriate factor. Similar findings for one or two, but not always the same, items have been reported not loading to the appropriate factor in many other studies. Most studies report the two factor structure of the HADS [2, 7], though there are some exceptions that have reported one factor , or three [10, 17, 24], or even four factors . The study of Mykletun et al. with 51,930 participants, which is the largest of all in the literature, concluded a bidimensional structure for the HADS was correct .
The HADS property of consisting of two independent subscales can also be shown by its correlations with the scales that were used as gold standards for depression and anxiety. The HADS/anxiety correlated highly with the STAI and the HADS/depression correlated highly with the BDI. There are some studies where the total HADS showed greater correlations than its subscales with BDI and STAI correspondingly [8, 12, 16, 25], but in our study the total HADS correlated to almost the same levels as its corresponding subscales with BDI and STAI (a little higher than HADS/depression with BDI, and a little lower than HADS/anxiety with STAI). It is worth noting that the two HADS subscales had a moderate correlation (0.559) to each other. This could be expected, bearing in mind that depression and anxiety show great comorbidity, especially in general health care settings .
There are some limitations in our study; there were gender and age differences between the groups, and the test-retest reliability was carried out with the control group only.
The findings of the present study suggest that the Greek version of the HADS is acceptable, reliable and valid. It could be used in general hospitals to assess depression and anxiety, helping clinicians identify patients who need special psychiatric care.
Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983, 67: 361-370. 10.1111/j.1600-0447.1983.tb09716.x.
Herrmann C: International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. J Psychosom Res. 1997, 42: 17-41. 10.1016/S0022-3999(96)00216-4.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 1961, 4:561-71.: 561-571.
Lykouras E, Loannidis C, Voulgari A, Jemos J, Tzonou A: Depression among general hospital patients in Greece. Acta Psychiatr Scand. 1989, 79: 148-152. 10.1111/j.1600-0447.1989.tb08582.x.
Bottomley A: Depression in cancer patients: a literature review. Eur J Cancer Care (Engl ). 1998, 7: 181-191. 10.1046/j.1365-2354.1998.00100.x.
Costantini M, Musso M, Viterbori P, Bonci F, Del ML, Garrone O, Venturini M, Morasso G: Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer. 1999, 7: 121-127. 10.1007/s005200050241.
Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002, 52: 69-77. 10.1016/S0022-3999(01)00296-3.
Lisspers J, Nygren A, Soderman E: Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand. 1997, 96: 281-286. 10.1111/j.1600-0447.1997.tb10164.x.
Mykletun A, Stordal E, Dahl AA: Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry. 2001, 179:540-4.: 540-544. 10.1192/bjp.179.6.540.
Leung CM, Ho S, Kan CS, Hung CH, Chen CN: Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective. Int J Psychosom. 1993, 40: 29-34.
Johnston M, Pollard B, Hennessey P: Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res. 2000, 48: 579-584. 10.1016/S0022-3999(00)00102-1.
Malasi TH, Mirza IA, el-Islam MF: Validation of the Hospital Anxiety and Depression Scale in Arab patients. Acta Psychiatr Scand. 1991, 84: 323-326. 10.1111/j.1600-0447.1991.tb03153.x.
Quintana JM, Padierna A, Esteban C, Arostegui I, Bilbao A, Ruiz I: Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 2003, 107: 216-221. 10.1034/j.1600-0447.2003.00062.x.
Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM: A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997, 27: 363-370. 10.1017/S0033291796004382.
Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, Robertson B, Bliss J: The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry. 1991, 158:255-9.: 255-259.
Razavi D, Delvaux N, Farvacques C, Robaye E: Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry. 1990, 156:79-83.: 79-83.
Sigurdardottir V, Bolund C, Brandberg Y, Sullivan M: The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res. 1993, 2: 193-203. 10.1007/BF00435223.
Savard J, Laberge B, Gauthier JG, Ivers H, Bergeron MG: Evaluating anxiety and depression in HIV-infected patients. J Pers Assess. 1998, 71: 349-367. 10.1207/s15327752jpa7103_5.
Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L: The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Support Care Cancer. 2004, 12: 821-825. 10.1007/s00520-004-0698-y.
Jemos J: Beck Depression Inventory; validation in a Greek sample. 1984, Athens University Medical School
Spielberger CD, Gorsuch RL, Lushene RE: Manual for the State-Trait Anxiety Inventory. 1970, Palo Alto, California, Consulting Psychologists Press
Liakos A, Giannitsi S: Reliability and validity of the Greek translation of the Spielberger's Anxiety Inventory. Engefalos. 1984, 21: 71-76.
Olsson I, Mykletun A, Dahl AA: The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005, 5:46.: 46-10.1186/1471-244X-5-46.
Lewis G: Observer bias in the assessment of anxiety and depression. Soc Psychiatry Psychiatr Epidemiol. 1991, 26: 265-272. 10.1007/BF00789218.
Silverstone PH: Poor efficacy of the Hospital Anxiety and Depression Scale in the diagnosis of major depressive disorder in both medical and psychiatric patients. J Psychosom Res. 1994, 38: 441-450. 10.1016/0022-3999(94)90105-8.
Sartorius N, Ustun TB, Lecrubier Y, Wittchen HU: Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl. 1996, 38-43.
IM was co-designer of the study and drafted the manuscript, AD participated in data collection and drafted the manuscript, CK participated in data collection and processing, CC participated in data collection and revised the manuscript, PM participated in data collection and revised the manuscript, GK was co-designer of the study and participated in data collection, KF participated in data collection and processing, PP participated in data collection and processing, KP participated in data collection and processing, and LL was co-designer of the study and gave final approval to the published version. All authors read and approved the final manuscript.
Ioannis Michopoulos, Athanasios Douzenis, Christina Kalkavoura, Christos Christodoulou, Panayiota Michalopoulou, Georgia Kalemi, Katerina Fineti, Paulos Patapis, Konstantinos Protopapas contributed equally to this work.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Michopoulos, I., Douzenis, A., Kalkavoura, C. et al. Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Ann Gen Psychiatry 7, 4 (2008). https://doi.org/10.1186/1744-859X-7-4
- Beck Depression Inventory
- Palliative Care Unit
- Doubtful Case
- Valid Case
- Greek Version